Stocks and Investing Stocks and Investing
Thu, November 16, 2023
Wed, November 15, 2023
Tue, November 14, 2023

Ed Arce Reiterated (AKRO) at Strong Buy and Held Target at $40 on, Nov 14th, 2023


Published on 2024-10-28 07:34:53 - WOPRAI, Ed Arce
  Print publication without navigation


Ed Arce of HC Wainwright & Co., Reiterated "Akero Therapeutics, Inc." (AKRO) at Strong Buy and Held Target at $40 on, Nov 14th, 2023.

Ed has made no other calls on AKRO in the last 4 months.



There are 5 other peers that have a rating on AKRO. Out of the 5 peers that are also analyzing AKRO, 0 agree with Ed's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Ed


  • Eliana Merle of "UBS" Maintained at Strong Buy with Decreased Target to $39 on, Thursday, October 12th, 2023
  • Eric Joseph of "JP Morgan" Maintained at Buy with Decreased Target to $41 on, Wednesday, October 11th, 2023
  • Michael Ulz of "Morgan Stanley" Maintained at Buy with Decreased Target to $33 on, Wednesday, October 11th, 2023
  • Prakhar Agrawal of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $39 on, Wednesday, October 11th, 2023
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Increased Target to $60 on, Wednesday, September 13th, 2023